Methods The randomised, open-label, multinational, phase 3b SURPASS-6 trial (NCT04537923) was conducted at 135 medical research centres and hospitals in 15 countries and compared two recommended treatment intensification strategies in people with T2D and inadequate glycaemic control on basal insulin: addition of once-weekly tirzepatide versus addition of prandial insulin lispro
PubMed indexing shows approximately 100+ publications for BPC-157 (predominantly from one group) and 150+ publications for GHK-Cu (from multiple independent laboratories across the United States, South Korea, Iran, and Europe)
Many companies supply pure creatine, but others may add additional ingredients
In animal clinical studies, semaglutide has caused thyroid tumors
Twelve were aborted due to food noted in the upper gastrointestinal tract, and four of these patients were taking a GLP-1RA (all patients were taking dulaglutide)